The use of erythropoietin in cancer patients receiving radiation therapy

Dariusz M. Kowalski; Katarzyna Zajda; Maciej Krzakowski; Piotr Jaśkiewicz

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2000
vol. 4

Send email

Copy url:

abstract:

The use of erythropoietin in cancer patients receiving radiation therapy

Dariusz M. Kowalski

,

Katarzyna Zajda

,

Maciej Krzakowski

,

Piotr Jaśkiewicz

Współcz Onkol (2000) 1, 25-29

Online publish date: 2003/07/25

View full text Get citation

Anaemia is common in the course of malignancy. In approximately 20-60 % of patients anaemia is a significant clinical complication. The paper presents etiology and pathogenesis of anaemia in patients with neoplastic diseases. The characteristics and effects of erythropoietin are reviewed. The results of randomised clinical trials on the use of erythropoietin in cancer patients treated with radiotherapy and radiochemotherapy are presented.

keywords:

The use of erythropoietin in cancer patients receiving radiation therapy

Dariusz M. Kowalski , Katarzyna Zajda , Maciej Krzakowski , Piotr Jaśkiewicz

erythropoietin, anaemia, hemoglobine, malignant disease, radiation therapy, chemotherapy

Dariusz M. Kowalski

,

Katarzyna Zajda

,

Maciej Krzakowski

,

Piotr Jaśkiewicz